The Impact of Cancer on Major Bleeding and Stroke/Systemic Emboli in Patients Using Direct Oral Anticoagulants:From the Database of a Single-Center Registry

BACKGROUND: Few data are available on direct oral anticoagulant (DOAC) use in patients with cancer and atrial fibrillation (AF). METHODS: We retrospectively analyzed prospectively collected data from a single-center registryon 2,272 patients who tookDOACs for AF (apixaban:1,014; edoxaban:267; rivaro...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Atr Fibrillation
Glavni autori: Sato, Takao, Aizawa, Yoshifusa, Fuse, Koichi, Fujita, Satoshi, Ikeda, Yoshio, Kitazawa, Hitoshi, Takahashi, Minoru, Okabe, Masaaki
Format: Artigo
Jezik:Inglês
Izdano: Cardiofront, Inc 2018
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6533833/
https://ncbi.nlm.nih.gov/pubmed/31139289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4022/jafib.2105
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items